News
-
Media Release: New anti-cancer drugs put cancers to sleep…permanentlyA member of the CRC program, St Vincent’s Institute and Bio21 Institute, University of Melbourne’s Professor Michael Parker and his team contributed to the structural biology of the target proteins KAT6A and KAT6B, as well as the corresponding selective inhibitors.
-
Women of Bio21 - Julie RaltonJulie Ralton, Research Fellow, McConville Group, Department of Biochemistry and Molecular Biology.
-
Women of Bio21 - Xu LiXu Li, Research Fellow, Gras Group, Department of Chemical and Biomolecular Engineering
-
From decades to days: 3D modelling tuberculosisGaming-changing diagnostic tools developed by Bio21's Dr David Ascher, together with Associate Professor Justin Denholm and Malancha Karmakar.
-
Fighting back against the Australian blowflyEach year, blowfly infestation of sheep wool, skin and tissue, known as flystrike, results in $280 million losses to the wool industry, not to mention the suffering experienced by the animals themselves.
-
Women of Bio21 - Uta WilleAssociate Professor Uta Wille, School of Chemistry
-
Media Release: Genetics sheds light on the spread of tuberculosis bacteriaBio21's Kat Holt led a study published in Nature Genetics today that concluded that the strain of TB-causing bacteria known as the Beijing lineage, was responsible for 59 per cent of infections, and even more (75%) of those diagnosed in younger people.
-
Lloyd Hollenberg inducted into the Australian Academy of SciencesToday Bio21's Professor Lloyd Hollenberg, School of Physics, was inducted into the Australian Academy of Sciences as a Fellow.
-
Women of Bio21 - Florienne LoderMeet Florienne Loder, Communications and Engagement Advisor, Bio21 Institute, Faculty of Science
-
Women of Bio21 - Susann WudtkeMeet Susann Wudtke, Bio21 CSL Limited, Research Scientist.
